These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16543139)

  • 1. Chemical ligation--an unusual paradigm in protease inhibition.
    Stennicke HR; Salvesen GS
    Mol Cell; 2006 Mar; 21(6):727-8. PubMed ID: 16543139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid.
    Wang Y; Huang JC; Zhou ZL; Yang W; Guastella J; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1269-72. PubMed ID: 14980679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
    Frydrych I; Mlejnek P
    J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity.
    Sedelies KA; Ciccone A; Clarke CJ; Oliaro J; Sutton VR; Scott FL; Silke J; Susanto O; Green DR; Johnstone RW; Bird PI; Trapani JA; Waterhouse NJ
    Cell Death Differ; 2008 Apr; 15(4):708-17. PubMed ID: 18202705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors.
    Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G
    Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native chemical ligation in covalent caspase inhibition by p35.
    Lu M; Min T; Eliezer D; Wu H
    Chem Biol; 2006 Feb; 13(2):117-22. PubMed ID: 16492559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do plant caspases exist?
    Woltering EJ; van der Bent A; Hoeberichts FA
    Plant Physiol; 2002 Dec; 130(4):1764-9. PubMed ID: 12481059
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.
    Kopka K; Faust A; Keul P; Wagner S; Breyholz HJ; Höltke C; Schober O; Schäfers M; Levkau B
    J Med Chem; 2006 Nov; 49(23):6704-15. PubMed ID: 17154501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase inhibitors: viral, cellular and chemical.
    Callus BA; Vaux DL
    Cell Death Differ; 2007 Jan; 14(1):73-8. PubMed ID: 16946729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.
    Martin U; Jarasch N; Nestler M; Rassmann A; Munder T; Seitz S; Zell R; Wutzler P; Henke A
    Apoptosis; 2007 Mar; 12(3):525-33. PubMed ID: 17211569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.
    McStay GP; Salvesen GS; Green DR
    Cell Death Differ; 2008 Feb; 15(2):322-31. PubMed ID: 17975551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bauhinia Kunitz-type proteinase inhibitors: structural characteristics and biological properties.
    Oliva ML; Sampaio UM
    Biol Chem; 2008 Aug; 389(8):1007-13. PubMed ID: 18754727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penaeus monodon caspase is targeted by a white spot syndrome virus anti-apoptosis protein.
    Leu JH; Wang HC; Kou GH; Lo CF
    Dev Comp Immunol; 2008; 32(5):476-86. PubMed ID: 17905432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apoptosis of myeloid leukemia cell line HL60 induced by Bortezomib, a proteasome inhibitor].
    Fu YB; Sun QX; Meng FY; Xie J; Zhou GB
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2413-6. PubMed ID: 17156654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
    Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
    Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction.
    Dudich E; Semenkova L; Dudich I; Denesyuk A; Tatulov E; Korpela T
    FEBS J; 2006 Aug; 273(16):3837-49. PubMed ID: 16869888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosomes: protease activation platforms to die from.
    Adrain C; Brumatti G; Martin SJ
    Trends Biochem Sci; 2006 May; 31(5):243-7. PubMed ID: 16595176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
    Abhari BA; Davoodi J
    J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
    Dahl G; Sandström A; Akerblom E; Danielson UH
    Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.